Cipla Invests ₹50 Million in iCaltech — A Fresh Breath of Tech for Respiratory Care

Purchase Price: Approximately ₹50 million for 20% voting shares.
Stake Structure: An equity share along with preference shares.
iCaltech Focus: Respiratory diagnostic medical devices.
Revenue (FY25): Fixed at ₹6.70 crore.
Timeline: One-month closure of the transaction.
Strategic Intent: Harness the digital and device strengths of Cipla in lung health.

Unknown Apr 02, 2026 900 Views

Global pharma leader Cipla Ltd has entered into a definitive contract to buy a 20% share in Bengaluru's medical device firm iCaltech Innovations Private Limited for around ₹50 million. This is purely for building up Cipla's portfolio in the segment of respiratory care and strengthening it...